医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

GVK BIO Establishes the Largest Isotope Labeling Facility in India

2012年11月19日 PM03:25
このエントリーをはてなブックマークに追加


 

HYDERABAD, India

GVK Biosciences (GVK BIO), Asia’s leading Drug Discovery Research & Development organization, has received approvals from the Atomic Energy Regulatory Board (AERB), Government of India, to carry out 3H and 14C synthesis activities. This GLP compliant facility has state-of-the-art equipment to cater to the requirements of companies engaged in the fields of Drug Discovery and Development, Agro and Veterinary Chemicals, Cosmetics, Perfumery and Specialty Studies.

Speaking of this development, Manni Kantipudi, CEO, GVK BIO, said, “Several of our customers requested us to extend our chemistry services to include isotope labeling services. We listened to our customers and setup this state-of-the art facility which is the largest such facility in India. The facility has received all statutory approvals from the Atomic Energy Review Board of India.

About GVK Biosciences

GVK Biosciences (GVK BIO) is Asia’s leading contract research organization. GVK BIO provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain. Our discovery services consist of Chemistry, Biology and Informatics; the development services include Clinical Research, Clinical Pharmacology and Process R&D. GVK BIO’s diverse portfolio of nearly 200 customers includes some of the world’s largest pharmaceutical, biotechnology, agro, life-sciences companies and leading academic & research institutions. Please visit us at www.gvkbio.com to know more.

CONTACT

GVK Biosciences Private Limited
Sushant Datta
Dy General
Manager – Corporate Marketing
T 0091 40 66929999
E sushant.datta@gvkbio.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • アルヴォテックと富士製薬が日本でバイオシミラーを開発・商業化するための独占提携契約を締結
  • Alvotech与富士制药缔结排他性伙伴关系,在日本从事生物类似物的开发和商业化
  • Dynex Technologies获得CFDA核准,向中国供应AGILITY自动ELISA处理系统
  • Alvotech and Fuji Pharma Enter into Exclusive Partnership for Development and Commercialization of Biosimilars in Japan
  • SANYEI CORPORATION Based in Japan Launches ION-Sei™ into the UK Market in Time for the Christmas Season. A Unique Electric Toothbrush That Uses Patented Technology to Suppress Bacteria That Cause Plaque and Gum Disease